MITAPIVAT

MITAPIVAT was reported 1331 times

MITAPIVAT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LIVER IRON CONCENTRATION DECREASED 1 0.5000
1 FREE FATTY ACIDS DECREASED 1 0.2500
2 RETICULOCYTE HAEMOGLOBIN DECREASED 1 0.1429
3 PYRUVATE KINASE DEFICIENCY ANAEMIA 1 0.1111
4 TESTICULAR RUPTURE 1 0.0833
5 CONCOMITANT DRUG EFFECT DECREASED 3 0.0698
6 HEPATITIS C RNA DECREASED 1 0.0667
7 HAPTOGLOBIN ABNORMAL 4 0.0435
8 INCREASED NEED FOR SLEEP 9 0.0386
9 SERUM FERRITIN ABNORMAL 8 0.0250
10 DELAYED SLEEP PHASE 2 0.0244
11 VESSEL PUNCTURE SITE SWELLING 1 0.0244
12 BEREAVEMENT 1 0.0217
13 BLAST CELLS 1 0.0192
14 RETICULOCYTE COUNT ABNORMAL 2 0.0179
15 ADVERSE EVENT FOLLOWING IMMUNISATION 1 0.0179
16 LACK OF CONCOMITANT DRUG EFFECT 1 0.0175
17 ABDOMINAL WALL OEDEMA 1 0.0159
18 OVERWORK 1 0.0128
19 CATHETER SITE DISCOMFORT 1 0.0125
20 BLOOD BILIRUBIN ABNORMAL 14 0.0109
21 BLOOD IRON INCREASED 19 0.0101
22 VASCULAR SKIN DISORDER 1 0.0101
23 EAR DRYNESS 1 0.0095
24 VESSEL PUNCTURE SITE PAIN 1 0.0094
25 PACKAGING DESIGN ISSUE 3 0.0091
26 RETICULOCYTE COUNT INCREASED 7 0.0087
27 OVERGROWTH BACTERIAL 2 0.0074
28 IRON OVERLOAD 8 0.0074
29 TESTICULAR TORSION 1 0.0069
30 RED BLOOD CELL MORPHOLOGY ABNORMAL 1 0.0065
31 MEDICAL DEVICE SITE JOINT INFECTION 1 0.0064
32 BLOOD FOLATE INCREASED 1 0.0060
33 BLOOD LACTATE DEHYDROGENASE ABNORMAL 4 0.0059
34 HEPATIC VASCULAR THROMBOSIS 1 0.0052
35 VESSEL PUNCTURE SITE BRUISE 1 0.0050
36 SCHWANNOMA 1 0.0050
37 CARDIAC NEOPLASM UNSPECIFIED 1 0.0050
38 SUSPECTED DRUG-INDUCED LIVER INJURY 1 0.0050
39 HAEMOGLOBIN ABNORMAL 31 0.0048
40 MONOCYTE COUNT ABNORMAL 1 0.0045
41 VERY LOW DENSITY LIPOPROTEIN INCREASED 1 0.0045
42 SICKLE CELL DISEASE 2 0.0043
43 OLIGODIPSIA 1 0.0043
44 HAEMATOCRIT ABNORMAL 5 0.0041
45 SERUM FERRITIN INCREASED 21 0.0040
46 OCULAR ICTERUS 17 0.0039
47 LIVER TENDERNESS 1 0.0036
48 EXCESSIVE SKIN 1 0.0035
49 STEROID THERAPY 1 0.0035
50 RESTRICTIVE CARDIOMYOPATHY 1 0.0033
51 OESTRADIOL DECREASED 1 0.0031
52 PRODUCT PACKAGING DIFFICULT TO OPEN 8 0.0031
53 COAGULATION TIME SHORTENED 1 0.0030
54 VIRAL DIARRHOEA 1 0.0029
55 TRANSFERRIN SATURATION INCREASED 1 0.0029
56 PRODUCT BLISTER PACKAGING ISSUE 3 0.0029
57 BLOOD OESTROGEN DECREASED 2 0.0028
58 OESOPHAGEAL MOTILITY DISORDER 1 0.0028
59 TIME PERCEPTION ALTERED 1 0.0028
60 INFECTION SUSCEPTIBILITY INCREASED 6 0.0027
61 RESPIRATORY GAS EXCHANGE DISORDER 1 0.0027
62 PRODUCT DISTRIBUTION ISSUE 25 0.0027
63 CAPILLARY DISORDER 1 0.0026
64 DIARRHOEA INFECTIOUS 2 0.0025
65 BIOPSY LIVER 1 0.0024
66 RETICULOCYTE COUNT DECREASED 1 0.0023
67 TRANSFUSION REACTION 2 0.0023
68 HAEMOGLOBIN DECREASED 230 0.0022
69 ENLARGED UVULA 1 0.0022
70 OSTOMY BAG PLACEMENT 1 0.0022
71 LAPAROTOMY 1 0.0022
72 BILIARY SEPSIS 1 0.0022
73 CENTRAL VENOUS CATHETER REMOVAL 1 0.0021
74 MEAN CELL VOLUME ABNORMAL 1 0.0021
75 BLOOD IRON ABNORMAL 2 0.0020
76 GRIEF REACTION 1 0.0019
77 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 1 0.0019
78 PRODUCT DOSE OMISSION IN ERROR 51 0.0018
79 SERUM FERRITIN DECREASED 3 0.0017
80 MEAN PLATELET VOLUME INCREASED 1 0.0017
81 LARGE INTESTINE INFECTION 2 0.0016
82 BLOOD BILIRUBIN DECREASED 1 0.0016
83 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
84 SICKLE CELL ANAEMIA 1 0.0016
85 SMALL INTESTINE ULCER 1 0.0015
86 YELLOW SKIN 7 0.0015
87 BONE DEFORMITY 1 0.0015
88 THROAT LESION 1 0.0015
89 PAINFUL ERECTION 1 0.0014
90 PREGNANCY OF PARTNER 1 0.0014
91 IMMUNISATION REACTION 1 0.0014
92 CHYLOTHORAX 1 0.0014
93 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
94 INITIAL INSOMNIA 14 0.0014
95 OTITIS MEDIA ACUTE 1 0.0014
96 VEIN COLLAPSE 1 0.0013
97 PRODUCT CONFUSION 1 0.0013
98 GOUTY ARTHRITIS 1 0.0013
99 HAPTOGLOBIN DECREASED 1 0.0012
100 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
101 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
102 CONGENITAL CYSTIC KIDNEY DISEASE 1 0.0012
103 POLYMENORRHOEA 4 0.0012
104 ABDOMINAL LYMPHADENOPATHY 1 0.0012
105 CHROMATURIA 26 0.0012
106 SELF-DESTRUCTIVE BEHAVIOUR 1 0.0011
107 PROTEIN TOTAL INCREASED 3 0.0011
108 HAEMOCHROMATOSIS 1 0.0011
109 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
110 EXERCISE TOLERANCE DECREASED 6 0.0010
111 HAEMOLYSIS 8 0.0010
112 BRAIN FOG 16 0.0010
113 CARDIAC ANEURYSM 1 0.0010
114 GENITAL HYPOAESTHESIA 1 0.0010
115 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
116 POST PROCEDURAL DISCOMFORT 2 0.0010
117 SLEEP DEFICIT 2 0.0009
118 BONE DEMINERALISATION 1 0.0009
119 VULVOVAGINAL DRYNESS 3 0.0009
120 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
121 CARBON DIOXIDE DECREASED 1 0.0009
122 MACROCYTOSIS 1 0.0009
123 PAROTITIS 1 0.0009
124 PRURITUS ALLERGIC 1 0.0009
125 BILIRUBIN CONJUGATED INCREASED 2 0.0009
126 INCISION SITE PAIN 1 0.0009
127 PNEUMONIA INFLUENZAL 1 0.0008
128 BLEEDING TIME PROLONGED 1 0.0008
129 PHARYNGEAL INFLAMMATION 1 0.0008
130 OTITIS EXTERNA 1 0.0008
131 POST-ACUTE COVID-19 SYNDROME 1 0.0008
132 LIP DISCOLOURATION 1 0.0008
133 TESTICULAR SWELLING 1 0.0008
134 ANION GAP INCREASED 1 0.0007
135 GLYCOSURIA 1 0.0007
136 JOINT INSTABILITY 1 0.0007
137 THERAPY NON-RESPONDER 32 0.0007
138 INTESTINAL FISTULA 1 0.0007
139 NEUROENDOCRINE TUMOUR 1 0.0007
140 NOROVIRUS INFECTION 1 0.0007
141 PRODUCT DOSE OMISSION ISSUE 197 0.0007
142 JAUNDICE 18 0.0007
143 BLOOD BILIRUBIN INCREASED 18 0.0007
144 MANTLE CELL LYMPHOMA 1 0.0007
145 FAMILY STRESS 2 0.0006
146 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
147 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
148 MENSTRUAL DISORDER 5 0.0006
149 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
150 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
151 TYMPANIC MEMBRANE PERFORATION 1 0.0006
152 MIDDLE INSOMNIA 11 0.0006
153 TONGUE COATED 1 0.0006
154 FULL BLOOD COUNT ABNORMAL 6 0.0006
155 IMPAIRED WORK ABILITY 12 0.0006
156 HAEMOLYTIC ANAEMIA 5 0.0006
157 HEAVY MENSTRUAL BLEEDING 5 0.0006
158 MONOCYTE COUNT INCREASED 2 0.0006
159 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
160 BLOOD URIC ACID INCREASED 3 0.0005
161 MOTION SICKNESS 1 0.0005
162 SICKLE CELL ANAEMIA WITH CRISIS 8 0.0005
163 SMALL INTESTINAL HAEMORRHAGE 1 0.0005
164 OSTEOLYSIS 1 0.0005
165 CHANGE OF BOWEL HABIT 1 0.0005
166 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
167 EAR SWELLING 1 0.0005
168 PRODUCT DISPENSING ISSUE 2 0.0005
169 INSOMNIA 124 0.0005
170 HENOCH-SCHONLEIN PURPURA 1 0.0005
171 MIDDLE EAR EFFUSION 1 0.0005
172 INFECTIOUS MONONUCLEOSIS 1 0.0004
173 LABORATORY TEST ABNORMAL 13 0.0004
174 URINE ABNORMALITY 2 0.0004
175 HAEMOGLOBIN INCREASED 2 0.0004
176 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
177 HYPERTRANSAMINASAEMIA 3 0.0004
178 IMPLANT SITE INFECTION 1 0.0004
179 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
180 DISCOURAGEMENT 1 0.0004
181 WEIGHT ABNORMAL 1 0.0004
182 WRONG DOSE 1 0.0004
183 SLOW SPEECH 1 0.0004
184 HORMONE LEVEL ABNORMAL 2 0.0004
185 THERAPY CHANGE 4 0.0004
186 ARTHROPOD BITE 3 0.0004
187 FOOT OPERATION 2 0.0004
188 LABYRINTHITIS 1 0.0004
189 BONE PAIN 23 0.0004
190 THIRST 7 0.0004
191 ABDOMINAL INFECTION 1 0.0004
192 MEAN CELL VOLUME INCREASED 1 0.0004
193 MENOPAUSE 1 0.0004
194 CATHETER SITE PAIN 1 0.0004
195 PLATELET COUNT INCREASED 5 0.0004
196 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
197 ANIMAL BITE 1 0.0004
198 POOR QUALITY SLEEP 8 0.0004
199 SHOULDER ARTHROPLASTY 1 0.0004
200 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
201 DEAFNESS UNILATERAL 2 0.0004
202 RED BLOOD CELL COUNT INCREASED 1 0.0004
203 INTERMENSTRUAL BLEEDING 2 0.0004
204 NEUTROPHIL COUNT ABNORMAL 1 0.0004
205 HAEMATOCRIT DECREASED 7 0.0004
206 HEART VALVE INCOMPETENCE 1 0.0003
207 MUSCLE STRAIN 3 0.0003
208 METABOLIC DISORDER 2 0.0003
209 PULMONARY PAIN 1 0.0003
210 DEVICE POWER SOURCE ISSUE 1 0.0003
211 URINE ODOUR ABNORMAL 2 0.0003
212 SLEEP DISORDER 24 0.0003
213 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
214 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
215 BLOOD IRON DECREASED 4 0.0003
216 PULMONARY HYPERTENSION 7 0.0003
217 GASTROENTERITIS VIRAL 6 0.0003
218 LOSS OF EMPLOYMENT 1 0.0003
219 CRANIOCEREBRAL INJURY 1 0.0003
220 EYE INJURY 1 0.0003
221 PORTAL HYPERTENSION 1 0.0003
222 TESTICULAR PAIN 1 0.0003
223 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
224 LYMPHOCYTE COUNT INCREASED 1 0.0003
225 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
226 FULL BLOOD COUNT DECREASED 6 0.0003
227 TONGUE ULCERATION 1 0.0003
228 HEPATIC CYST 1 0.0003
229 SLUGGISHNESS 3 0.0003
230 HEPATIC FIBROSIS 1 0.0003
231 BLOOD CREATININE ABNORMAL 1 0.0003
232 TACHYPHRENIA 1 0.0003
233 FIBRIN D DIMER INCREASED 1 0.0003
234 PRODUCT SUPPLY ISSUE 2 0.0003
235 LIVER FUNCTION TEST INCREASED 6 0.0003
236 HYPERSOMNIA 8 0.0003
237 GRAFT VERSUS HOST DISEASE 2 0.0003
238 RENAL TRANSPLANT 1 0.0003
239 HEADACHE 173 0.0003
240 BACK PAIN 64 0.0003
241 LIVER TRANSPLANT 1 0.0003
242 CAROTID ARTERY OCCLUSION 1 0.0003
243 FOOD INTOLERANCE 1 0.0003
244 BONE DENSITY ABNORMAL 1 0.0003
245 CHEMOTHERAPY 1 0.0003
246 ILLNESS 27 0.0003
247 LIMB INJURY 7 0.0003
248 PALLOR 7 0.0003
249 SPLENOMEGALY 3 0.0003
250 CARDIOMEGALY 3 0.0002
251 SOCIAL PROBLEM 1 0.0002
252 SLEEP TERROR 1 0.0002
253 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
254 POOR PERIPHERAL CIRCULATION 1 0.0002
255 THERAPY CESSATION 12 0.0002
256 HORDEOLUM 1 0.0002
257 CHAPPED LIPS 1 0.0002
258 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
259 DIVERTICULUM INTESTINAL 1 0.0002
260 TOOTH INFECTION 3 0.0002
261 GINGIVAL SWELLING 1 0.0002
262 ABDOMINAL ABSCESS 1 0.0002
263 GOUT 4 0.0002
264 DISTURBANCE IN ATTENTION 12 0.0002
265 VASCULAR DEVICE INFECTION 1 0.0002
266 LIP DRY 2 0.0002
267 PRODUCT AVAILABILITY ISSUE 5 0.0002
268 TREATMENT NONCOMPLIANCE 12 0.0002
269 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
270 ABDOMINAL HERNIA 1 0.0002
271 EAR DISORDER 1 0.0002
272 DYSPAREUNIA 1 0.0002
273 INCREASED TENDENCY TO BRUISE 2 0.0002
274 NERVE COMPRESSION 2 0.0002
275 RENAL FUNCTION TEST ABNORMAL 1 0.0002
276 ROSACEA 1 0.0002
277 PERFORMANCE STATUS DECREASED 1 0.0002
278 FLANK PAIN 2 0.0002
279 SEASONAL ALLERGY 3 0.0002
280 SKIN ABRASION 1 0.0002
281 SPUTUM DISCOLOURED 2 0.0002
282 CARDIAC TAMPONADE 1 0.0002
283 INCREASED APPETITE 4 0.0002
284 CARDIOGENIC SHOCK 3 0.0002
285 ATELECTASIS 2 0.0002
286 GASTROENTERITIS 3 0.0002
287 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
288 PHARYNGEAL SWELLING 2 0.0002
289 FATIGUE 159 0.0002
290 HEPATOMEGALY 2 0.0002
291 STAPHYLOCOCCAL SEPSIS 1 0.0002
292 HYPERVOLAEMIA 1 0.0002
293 PRODUCT USE ISSUE 38 0.0002
294 BLOOD PRESSURE ABNORMAL 4 0.0002
295 ARTHRALGIA 82 0.0002
296 AMMONIA INCREASED 1 0.0002
297 EAR DISCOMFORT 2 0.0002
298 PETECHIAE 2 0.0002
299 TONSILLITIS 1 0.0002
300 FOOD CRAVING 1 0.0002
301 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
302 ADVERSE DRUG REACTION 17 0.0002
303 RENAL PAIN 2 0.0002
304 FOOD POISONING 1 0.0002
305 BACK INJURY 2 0.0002
306 MEMORY IMPAIRMENT 25 0.0002
307 ASTHENOPIA 1 0.0002
308 GASTRIC ULCER HAEMORRHAGE 1 0.0002
309 VIRAL INFECTION 6 0.0002
310 STREPTOCOCCAL INFECTION 1 0.0002
311 NECROSIS 1 0.0002
312 INFLUENZA 20 0.0002
313 HEART RATE ABNORMAL 1 0.0002
314 COVID-19 31 0.0002
315 CARDIAC VALVE DISEASE 1 0.0002
316 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
317 HEART RATE INCREASED 17 0.0002
318 ENERGY INCREASED 1 0.0002
319 BRADYKINESIA 1 0.0002
320 SINUS HEADACHE 1 0.0002
321 TOOTHACHE 3 0.0002
322 PLATELET COUNT ABNORMAL 1 0.0002
323 LOCALISED INFECTION 4 0.0002
324 PELVIC PAIN 3 0.0002
325 BONE DISORDER 3 0.0002
326 DECREASED APPETITE 38 0.0002
327 TENDON RUPTURE 2 0.0002
328 TOOTH EXTRACTION 2 0.0002
329 BLEPHAROSPASM 1 0.0002
330 FEELING JITTERY 3 0.0002
331 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
332 ATRIAL FIBRILLATION 15 0.0002
333 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
334 JOINT STIFFNESS 4 0.0002
335 NASOPHARYNGITIS 28 0.0002
336 APPETITE DISORDER 1 0.0002
337 SKIN MASS 1 0.0001
338 DRY MOUTH 12 0.0001
339 HEPATIC ENZYME INCREASED 10 0.0001
340 OSTEOPOROSIS 6 0.0001
341 ABDOMINAL PAIN UPPER 30 0.0001
342 ABNORMAL DREAMS 4 0.0001
343 BLOOD TEST ABNORMAL 2 0.0001
344 OFF LABEL USE 123 0.0001
345 INTENTIONAL DOSE OMISSION 4 0.0001
346 RED BLOOD CELL COUNT DECREASED 4 0.0001
347 ASTHENIA 52 0.0001
348 ABDOMINAL DISCOMFORT 23 0.0001
349 INTENTIONAL UNDERDOSE 1 0.0001
350 ORAL DISORDER 1 0.0001
351 PSYCHIATRIC SYMPTOM 1 0.0001
352 FEELING DRUNK 1 0.0001
353 BONE LOSS 2 0.0001
354 BREAST TENDERNESS 1 0.0001
355 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
356 INSURANCE ISSUE 2 0.0001
357 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
358 MUSCULOSKELETAL CHEST PAIN 2 0.0001
359 ANKLE FRACTURE 2 0.0001
360 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
361 FURUNCLE 1 0.0001
362 THERAPY INTERRUPTED 9 0.0001
363 ATRIAL FLUTTER 1 0.0001
364 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
365 BLOOD DISORDER 1 0.0001
366 RHINORRHOEA 8 0.0001
367 MUSCLE TIGHTNESS 2 0.0001
368 BLOOD CREATININE INCREASED 8 0.0001
369 LIVER INJURY 3 0.0001
370 SPINAL COMPRESSION FRACTURE 1 0.0001
371 EOSINOPHIL COUNT INCREASED 1 0.0001
372 PALPITATIONS 14 0.0001
373 BLOOD UREA INCREASED 2 0.0001
374 NASAL CONGESTION 7 0.0001
375 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
376 PRODUCT CONTAINER ISSUE 1 0.0001
377 SKIN HYPERPIGMENTATION 1 0.0001
378 MALAISE 51 0.0001
379 DIZZINESS 56 0.0001
380 MYALGIA 19 0.0001
381 LOSS OF LIBIDO 1 0.0001
382 MOOD ALTERED 3 0.0001
383 BRAIN NEOPLASM 1 0.0001
384 NAUSEA 86 0.0001
385 ADVERSE EVENT 10 0.0001
386 UROSEPSIS 1 0.0001
387 PROCEDURAL PAIN 3 0.0001
388 ABDOMINAL PAIN 25 0.0001
389 HEPATIC STEATOSIS 2 0.0001
390 NECK PAIN 6 0.0001
391 NEPHROPATHY 1 0.0001
392 CARDIAC DISORDER 10 0.0001
393 PRODUCT PACKAGING ISSUE 1 0.0001
394 MIGRAINE 10 0.0001
395 HERNIA 2 0.0001
396 DIZZINESS POSTURAL 1 0.0001
397 EAR PAIN 2 0.0001
398 KIDNEY INFECTION 2 0.0001
399 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
400 ARTHRITIS 8 0.0001
401 DISABILITY 2 0.0001
402 LIGAMENT SPRAIN 1 0.0001
403 DRUG INTERACTION 16 0.0001
404 RESPIRATORY DISORDER 3 0.0001
405 DRY THROAT 1 0.0001
406 BLOOD PRESSURE INCREASED 15 0.0001
407 BODY TEMPERATURE INCREASED 2 0.0001
408 NEUTROPHIL COUNT INCREASED 1 0.0001
409 EMOTIONAL DISORDER 3 0.0001
410 OROPHARYNGEAL PAIN 9 0.0001
411 SKELETAL INJURY 1 0.0001
412 HYPERBILIRUBINAEMIA 1 0.0001
413 FEELING ABNORMAL 23 0.0001
414 BONE DENSITY DECREASED 3 0.0001
415 ROAD TRAFFIC ACCIDENT 4 0.0001
416 SCRATCH 1 0.0001
417 INCONTINENCE 1 0.0001
418 MOOD SWINGS 3 0.0001
419 EATING DISORDER 2 0.0001
420 IRRITABLE BOWEL SYNDROME 2 0.0001
421 DRUG INTOLERANCE 9 0.0001
422 NIGHT SWEATS 3 0.0001
423 HOT FLUSH 7 0.0001
424 DECREASED ACTIVITY 1 0.0001
425 PHARYNGITIS STREPTOCOCCAL 1 0.0001
426 PULMONARY THROMBOSIS 1 0.0001
427 CHOLELITHIASIS 3 0.0001
428 INTENTIONAL PRODUCT MISUSE 8 0.0001
429 IMPAIRED HEALING 3 0.0001
430 TACHYCARDIA 8 0.0001
431 HYPERTENSIVE CRISIS 1 0.0001
432 EYE INFECTION 1 0.0001
433 HEART RATE IRREGULAR 2 0.0001
434 IMPAIRED DRIVING ABILITY 1 0.0001
435 NEOPLASM 1 0.0001
436 GASTRIC HAEMORRHAGE 1 0.0001
437 PERICARDIAL EFFUSION 2 0.0001
438 POST PROCEDURAL HAEMORRHAGE 1 0.0001
439 HYPOXIA 3 0.0001
440 LYMPHADENOPATHY 3 0.0001
441 SOMNOLENCE 17 0.0001
442 CHOLECYSTITIS 1 0.0001
443 ACCIDENT 1 0.0001
444 MACULAR DEGENERATION 1 0.0001
445 WRIST FRACTURE 1 0.0001
446 NOCTURIA 1 0.0001
447 PANIC ATTACK 3 0.0001
448 DISCOMFORT 5 0.0001
449 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
450 BRONCHITIS 6 0.0001
451 DYSGEUSIA 6 0.0001
452 PHARYNGITIS 1 0.0001
453 CYST 1 0.0001
454 ILEUS 1 0.0001
455 ABDOMINAL PAIN LOWER 2 0.0001
456 MUSCLE ATROPHY 1 0.0001
457 HYPOPHAGIA 2 0.0001
458 PAIN IN EXTREMITY 23 0.0001
459 ERECTILE DYSFUNCTION 2 0.0001
460 SWELLING FACE 5 0.0001
461 PAIN 47 0.0001
462 URINARY TRACT INFECTION 13 0.0001
463 BEDRIDDEN 1 0.0001
464 SARS-COV-2 TEST POSITIVE 1 0.0001
465 DYSMENORRHOEA 1 0.0001
466 ADVERSE REACTION 1 0.0001
467 DEHYDRATION 10 0.0001
468 QUALITY OF LIFE DECREASED 1 0.0001
469 SINUS CONGESTION 1 0.0001
470 ANXIETY 21 0.0001
471 TACHYPNOEA 1 0.0001
472 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
473 PERIPHERAL COLDNESS 1 0.0001
474 DYSPNOEA 41 0.0001
475 DEMENTIA 2 0.0001
476 MASS 1 0.0001
477 DYSPEPSIA 7 0.0001
478 PAIN IN JAW 2 0.0001
479 FLATULENCE 4 0.0001
480 CHEST PAIN 13 0.0001
481 LETHARGY 4 0.0001
482 LIVER DISORDER 3 0.0001
483 SKIN HAEMORRHAGE 1 0.0001
484 ABDOMINAL DISTENSION 7 0.0001
485 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
486 THROAT IRRITATION 3 0.0001
487 BLOOD POTASSIUM DECREASED 2 0.0001
488 HYPOAESTHESIA ORAL 1 0.0001
489 CHRONIC KIDNEY DISEASE 5 0.0001
490 VERTIGO 4 0.0001
491 DEVICE RELATED INFECTION 1 0.0001
492 THYROID DISORDER 1 0.0001
493 LYMPHOMA 1 0.0001
494 FEMUR FRACTURE 2 0.0001
495 CONSTIPATION 14 0.0001
496 HEAD INJURY 2 0.0001
497 PRODUCTIVE COUGH 3 0.0001
498 CONTUSION 6 0.0001
499 SENSORY DISTURBANCE 1 0.0001
500 HIP FRACTURE 2 0.0001
501 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
502 BACK DISORDER 1 0.0001
503 LUNG DISORDER 3 0.0001
504 INFLUENZA LIKE ILLNESS 5 0.0001
505 PHOTOSENSITIVITY REACTION 1 0.0001
506 HYPOAESTHESIA 9 0.0001
507 LIP SWELLING 2 0.0001
508 COAGULOPATHY 1 0.0001
509 GAIT INABILITY 2 0.0001
510 EYE PRURITUS 2 0.0001
511 RENAL IMPAIRMENT 5 0.0001
512 HYPERSENSITIVITY 11 0.0001
513 CANDIDA INFECTION 1 0.0001
514 SINUSITIS 6 0.0001
515 PYREXIA 20 0.0001
516 DRUG INEFFECTIVE 76 0.0001
517 VOMITING 27 0.0001
518 MUSCULOSKELETAL STIFFNESS 5 0.0001
519 EOSINOPHILIA 1 0.0001
520 DEPRESSED MOOD 3 0.0001
521 HEAD DISCOMFORT 1 0.0001
522 GASTROINTESTINAL DISORDER 5 0.0001
523 LEUKOCYTOSIS 1 0.0001
524 OSTEOMYELITIS 1 0.0001
525 CRYING 2 0.0001
526 RESTLESS LEGS SYNDROME 1 0.0001
527 BLOOD GLUCOSE ABNORMAL 1 0.0001
528 BACTERIAL INFECTION 1 0.0001
529 COUGH 15 0.0001
530 SWELLING 5 0.0001
531 HEPATIC CIRRHOSIS 1 0.0001
532 DYSPNOEA EXERTIONAL 2 0.0001
533 INTESTINAL OBSTRUCTION 2 0.0001
534 BLOOD SODIUM DECREASED 1 0.0001
535 FOOT FRACTURE 1 0.0001
536 BLOOD URINE PRESENT 1 0.0001
537 MUSCULOSKELETAL DISORDER 1 0.0001
538 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
539 LOWER LIMB FRACTURE 1 0.0001
540 PRESCRIBED OVERDOSE 1 0.0001
541 SKIN FISSURES 1 0.0001
542 PARAESTHESIA 8 0.0001
543 SINUS DISORDER 1 0.0001
544 ABNORMAL BEHAVIOUR 2 0.0001
545 UPPER LIMB FRACTURE 1 0.0001
546 PREGNANCY 1 0.0000
547 CARDIAC FAILURE 4 0.0000
548 CARDIAC FAILURE CONGESTIVE 4 0.0000
549 JOINT SWELLING 6 0.0000
550 DIARRHOEA 32 0.0000
551 PRODUCT ADMINISTRATION ERROR 1 0.0000
552 FEEDING DISORDER 1 0.0000
553 RIB FRACTURE 1 0.0000
554 INFECTION 7 0.0000
555 POLLAKIURIA 2 0.0000
556 MOUTH ULCERATION 1 0.0000
557 HYPERTENSION 10 0.0000
558 PLATELET COUNT DECREASED 5 0.0000
559 RETCHING 1 0.0000
560 HYPOACUSIS 2 0.0000
561 VAGINAL HAEMORRHAGE 2 0.0000
562 PRODUCT PRESCRIBING ISSUE 1 0.0000
563 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
564 TOOTH DISORDER 1 0.0000
565 HEPATOTOXICITY 1 0.0000
566 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
567 MUSCULAR WEAKNESS 5 0.0000
568 VISION BLURRED 6 0.0000
569 MUSCLE SPASMS 8 0.0000
570 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
571 RENAL DISORDER 2 0.0000
572 DYSPHAGIA 4 0.0000
573 ANAEMIA 8 0.0000
574 URTICARIA 7 0.0000
575 HEPATIC CANCER 1 0.0000
576 FIBROMYALGIA 1 0.0000
577 PNEUMONIA 13 0.0000
578 PNEUMONIA ASPIRATION 1 0.0000
579 CELLULITIS 2 0.0000
580 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
581 DEPRESSION 9 0.0000
582 CARDIOVASCULAR DISORDER 1 0.0000
583 FLUID RETENTION 2 0.0000
584 HEPATITIS 1 0.0000
585 INFLAMMATION 2 0.0000
586 SKIN ULCER 1 0.0000
587 NO ADVERSE EVENT 7 0.0000
588 RESPIRATORY TRACT INFECTION 1 0.0000
589 NERVOUSNESS 2 0.0000
590 DEAFNESS 1 0.0000
591 GASTRITIS 1 0.0000
592 EAR INFECTION 1 0.0000
593 THROAT TIGHTNESS 1 0.0000
594 PRURITUS 14 0.0000
595 HAEMATOCHEZIA 2 0.0000
596 FALL 12 0.0000
597 FEELING COLD 1 0.0000
598 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
599 SEPSIS 4 0.0000
600 WOUND 1 0.0000
601 OXYGEN SATURATION DECREASED 2 0.0000
602 EYE PAIN 2 0.0000
603 RHEUMATOID ARTHRITIS 4 0.0000
604 ANGINA PECTORIS 1 0.0000
605 EYE IRRITATION 2 0.0000
606 RASH 15 0.0000
607 DYSSTASIA 1 0.0000
608 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
609 DYSPHONIA 2 0.0000
610 CHILLS 4 0.0000
611 SURGERY 2 0.0000
612 ASCITES 1 0.0000
613 URINARY INCONTINENCE 1 0.0000
614 RENAL INJURY 1 0.0000
615 FEELING HOT 2 0.0000
616 PERIPHERAL SWELLING 5 0.0000
617 LIMB DISCOMFORT 1 0.0000
618 VISUAL IMPAIRMENT 4 0.0000
619 DRUG-INDUCED LIVER INJURY 1 0.0000
620 NEUROPATHY PERIPHERAL 3 0.0000
621 LOSS OF CONSCIOUSNESS 4 0.0000
622 MOVEMENT DISORDER 1 0.0000
623 CONFUSIONAL STATE 5 0.0000
624 EYE DISORDER 1 0.0000
625 SKIN DISORDER 1 0.0000
626 NEOPLASM MALIGNANT 2 0.0000
627 CHEST DISCOMFORT 3 0.0000
628 NIGHTMARE 1 0.0000
629 WEIGHT DECREASED 8 0.0000
630 RASH MACULAR 1 0.0000
631 C-REACTIVE PROTEIN INCREASED 1 0.0000
632 RESTLESSNESS 1 0.0000
633 HEPATIC FUNCTION ABNORMAL 1 0.0000
634 ASTHMA 3 0.0000
635 UNEVALUABLE EVENT 2 0.0000
636 ACNE 2 0.0000
637 DIABETES MELLITUS 2 0.0000
638 HOSPITALISATION 4 0.0000
639 DISORIENTATION 1 0.0000
640 HYPOTENSION 5 0.0000
641 THROMBOSIS 2 0.0000
642 EXTRA DOSE ADMINISTERED 1 0.0000
643 OEDEMA PERIPHERAL 3 0.0000
644 WITHDRAWAL SYNDROME 1 0.0000
645 OSTEOARTHRITIS 1 0.0000
646 HYPERHIDROSIS 3 0.0000
647 BALANCE DISORDER 2 0.0000
648 SEPTIC SHOCK 1 0.0000
649 MENTAL DISORDER 1 0.0000
650 RENAL FAILURE 3 0.0000
651 DRY SKIN 3 0.0000
652 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
653 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
654 NEPHROLITHIASIS 1 0.0000
655 TINNITUS 1 0.0000
656 BLOOD CHOLESTEROL INCREASED 1 0.0000
657 OCULAR HYPERAEMIA 1 0.0000
658 PULMONARY EMBOLISM 2 0.0000
659 RASH ERYTHEMATOUS 1 0.0000
660 BLOOD GLUCOSE DECREASED 1 0.0000
661 INTERSTITIAL LUNG DISEASE 1 0.0000
662 ALOPECIA 4 0.0000
663 DRY EYE 1 0.0000
664 SYNCOPE 2 0.0000
665 ECZEMA 1 0.0000
666 MUSCULOSKELETAL PAIN 1 0.0000
667 RASH PRURITIC 1 0.0000
668 ARTHROPATHY 1 0.0000
669 WEIGHT INCREASED 4 0.0000
670 WHEEZING 1 0.0000
671 CATARACT 1 0.0000
672 IRRITABILITY 1 0.0000
673 THERAPEUTIC RESPONSE DECREASED 1 0.0000
674 SUICIDE ATTEMPT 1 0.0000
675 STOMATITIS 1 0.0000
676 ILL-DEFINED DISORDER 1 0.0000
677 PLEURAL EFFUSION 1 0.0000
678 DEEP VEIN THROMBOSIS 1 0.0000
679 AMNESIA 1 0.0000
680 BLOOD PRESSURE DECREASED 1 0.0000
681 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
682 MOBILITY DECREASED 1 0.0000
683 AGITATION 1 0.0000
684 HALLUCINATION 1 0.0000
685 DRUG DOSE OMISSION BY DEVICE 1 0.0000
686 TREMOR 2 0.0000
687 SKIN EXFOLIATION 1 0.0000
688 CEREBROVASCULAR ACCIDENT 2 0.0000
689 PRODUCT STORAGE ERROR 1 0.0000
690 DEVICE ISSUE 1 0.0000
691 BLOOD GLUCOSE INCREASED 2 0.0000
692 THROMBOCYTOPENIA 1 0.0000
693 INCORRECT DOSE ADMINISTERED 2 0.0000
694 SEIZURE 1 0.0000
695 EMOTIONAL DISTRESS 1 0.0000
696 NEUTROPENIA 1 0.0000
697 CONDITION AGGRAVATED 2 0.0000
698 ACUTE KIDNEY INJURY 1 0.0000
699 MYOCARDIAL INFARCTION 1 0.0000
700 GAIT DISTURBANCE 1 0.0000
701 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
702 OVERDOSE 1 0.0000
703 DEATH 1 0.0000